APGE — APOGEE THERAPEUTICS INC

Ownership history in VR Adviser, LLC  ·  10 quarters on record

This page tracks every 13F SEC filing in which VR Adviser, LLC reported a position in APOGEE THERAPEUTICS INC (APGE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
31.67% (2025 Q4)
Avg. % of fund
24.13%
First filed
2023 Q3
Last filed
2025 Q4
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 8,493,321 — 0% 31.67% $641.1M $75.48
2025 Q3 UNCHANGED 8,493,321 — 0% 18.99% $337.4M $39.73
2025 Q2 UNCHANGED 8,493,321 — 0% 27.64% $368.9M $43.43
2025 Q1 UNCHANGED 8,493,321 — 0% 27.00% $317.3M $37.36
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    APGE price (monthly, adj. close)

Other funds also holding APGE

As of 2025 Q4 — sorted by position size

Remedium Capital Partners, LLC 25.88% Fairmount Funds Management LLC 3Y 11.77% GREAT POINT PARTNERS LLC 3Y 7Y 9.15% Affinity Asset Advisors, LLC 3Y 5.31% First Turn Management, LLC 4.1% Opaleye Management Inc. 3Y 7Y 3.87% Novo Holdings A/S 3Y 7Y 3.34% PERCEPTIVE ADVISORS LLC 3Y 7Y 3.14% Paradigm Biocapital Advisors LP 3Y 2.16% RTW INVESTMENTS, LP 3Y 7Y 2.05%
← Back to VR Adviser, LLC Holdings